Mepartricin

Known as: Methyl Partricin, Mepartricin [Chemical/Ingredient], Methylpartricin 
Polyene macrolide antibiotic with unknown composition. It is obtained from Streptomyces aureofaciens. It is used as an antifungal agent, an… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1974-2015
02419742015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
OBJECTIVES To verify the efficacy of mepartricin versus placebo with regard to symptom improvement in patients with chronic… (More)
Is this relevant?
2001
2001
The effects induced by oral administration of 0, 5 and 20 mg of meparticin kg(-1)of body weight for 28 days (group 1, 2 and 3… (More)
Is this relevant?
1998
1998
BACKGROUND Mepartricin, a semisynthetic polyene derivative with a favorable effect on urethro-prostatic function, was clinically… (More)
Is this relevant?
1996
1996
The authors assessed the validity of a treatment with mepartricin in BPH at the dose of 150,000 U in a once-a-day evening… (More)
Is this relevant?
1991
1991
The Authors propose a medical treatment for Benign Prostatic Hyperplasia (BPH) using mepartricina-simvastatina, two drugs with a… (More)
Is this relevant?
1991
1991
The polyenes, amphotericin B and mepartricin and the imidazoles, miconazole, ketoconazole, itraconazole and fluconazole, were… (More)
Is this relevant?
1989
1989
Amphotericin B (AmB) has been able to lengthen the incubation period of intracerebrally (ic) scrapie-injected hamsters to 45 d… (More)
Is this relevant?
1985
1985
An in-vitro comparison was made of the activity of mepartricin and amphotericin B against yeasts both in the presence and absence… (More)
Is this relevant?
1983
1983
Mepartricin, a new semisynthetic heptene, was given for systemic Candida infections to 11 immunocompromised patients. All… (More)
Is this relevant?
1978
1978
A "cross over" study was carried out in a group of 22 subjects with prostatic hypertrophy in different stages, first treated with… (More)
Is this relevant?